Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doran

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
HRB Open Research|April 15, 2021
The future of genomics in Ireland - focus on genomics for healthCathal Seoighe, Adrian P Bracken, Patrick Buckley, et al.
Journal of Immunological Methods|September 2, 2022
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccinationGrace Kenny, Riya Negi, Sophie O'Reilly, et al.
Trials|July 29, 2010
Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centresWolfgang Kuchinke, Christian Ohmann, Qin Yang, et al.
European Radiology Experimental|November 3, 2020
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRIHannah Fleming, Simon M Clifford, Aoife Haughey, et al.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
Frontiers in Medicine|September 13, 2021
Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the PandemicBrendan O'Kelly, Ronan McLaughlin, Roseann O'Doherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2025
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contactsJoanne Byrne, Colette Marie Gaillard, Lili Gu, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
HRB Open Research|April 15, 2021
The future of genomics in Ireland - focus on genomics for healthCathal Seoighe, Adrian P Bracken, Patrick Buckley, et al.
Journal of Immunological Methods|September 2, 2022
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccinationGrace Kenny, Riya Negi, Sophie O'Reilly, et al.
Trials|July 29, 2010
Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centresWolfgang Kuchinke, Christian Ohmann, Qin Yang, et al.
European Radiology Experimental|November 3, 2020
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRIHannah Fleming, Simon M Clifford, Aoife Haughey, et al.
Microbes and Infection|November 9, 2023
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severityRachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
Frontiers in Medicine|September 13, 2021
Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the PandemicBrendan O'Kelly, Ronan McLaughlin, Roseann O'Doherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2025
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contactsJoanne Byrne, Colette Marie Gaillard, Lili Gu, et al.
Pageof 8